GLP-1-mediated gene therapy approaches for diabetes treatment.

about

Sex difference of hyperinsulinemia in the C57BL/6J-Daruma (obese) mouse.

P2860

Q41435910-3B3181DB-E3CA-42F6-809E-D0D973302B3D

P2860

GLP-1-mediated gene therapy approaches for diabetes treatment.

Item

http://www.wikidata.org/entity/Q38199215

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

GLP-1-mediated gene therapy approaches for diabetes treatment.

@en

type

Item

label

GLP-1-mediated gene therapy approaches for diabetes treatment.

@en

prefLabel

GLP-1-mediated gene therapy approaches for diabetes treatment.

@en

P1476

GLP-1-mediated gene therapy approaches for diabetes treatment.

@en

P2093

Halit Canatan

http://www.w3.org/2001/XMLSchema#string

Hasan Ali Altunbas

http://www.w3.org/2001/XMLSchema#string

Mukerrem Hale Tasyurek

http://www.w3.org/2001/XMLSchema#string

Salih Sanlioglu

http://www.w3.org/2001/XMLSchema#string

Thomas S Griffith

http://www.w3.org/2001/XMLSchema#string

P2860

A role for glucagon-like peptide-1 in the central regulation of feeding

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

Therapeutic potential of VIP vs PACAP in diabetes

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

Strategic opportunities in clinical islet transplantation

Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis

Clinical utility of insulin and insulin analogs.

Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.

Systemic delivery of bioactive glucagon-like peptide 1 after adenoviral-mediated gene transfer in the murine salivary gland.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/ERM.2014.7

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261102056

http://www.w3.org/2001/XMLSchema#string

P698

24666581

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

GLP-1-mediated gene therapy approaches for diabetes treatment.

about

P2860

P2860

GLP-1-mediated gene therapy approaches for diabetes treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921